SMSbiotech Presents Investigational SMS Cell Platform at International Orthopedics Webinar
SAN DIEGO, CA — November 19, 2025 — SMSbiotech, a clinical-stage regenerative medicine company developing its proprietary Small Mobile Stem (SMS) cell platform, announced its participation in the 5th International Webinar on Orthopedics, Osteoporosis, and Musculoskeletal Disorders, held virtually from Paris, France on November 26–27, 2025.
The global scientific event convened clinicians, researchers, and industry professionals to explore advancements in orthopedic care and emerging technologies in musculoskeletal medicine. The program featured a broad range of presentations spanning surgical techniques, clinical research, and investigational therapeutic approaches.
On November 27, Dr. Abdulkader Rahmo, President of SMSbiotech, delivered a featured presentation titled:
“Small Mobile Stem (SMS) Cell Treatment Prospects for Orthopaedic Diseases.”
During the session, Dr. Rahmo introduced the scientific rationale behind SMS cells, a distinct class of adult-derived, non-genetically modified cells currently being investigated for their potential role in regenerative medicine. The presentation highlighted key biological characteristics of SMS cells, including their signaling-based mechanisms and potential applicability across orthopedic conditions.
“Scientific exchange is essential to advancing innovation in regenerative medicine,” said Dr. Rahmo. “We value the opportunity to contribute to global discussions and share insights from our ongoing research.”
The webinar, organized by Scientex Conferences, centered on the theme “Advancements in Technology for Orthopedics, Osteoporosis, and Musculoskeletal Disorders,” reflecting increasing interest in integrating biologic and technology-driven approaches into musculoskeletal care.
SMSbiotech’s participation highlights its continued engagement with the global scientific community and its efforts to advance research into SMS cells across multiple therapeutic areas. Orthopedic conditions—including degenerative joint diseases and musculoskeletal injuries—represent a significant area of ongoing research, where investigational approaches may offer new insights into addressing underlying biological processes.
